Revlimid vs Cosentyx
Side-by-side drug price comparison from Medicare Part D data
Verdict
Cosentyx costs 72% less per claim than Revlimid ($3616.00 vs $12786.00). Cosentyx has a generic alternative available. Total Medicare spending: Revlimid at $7.8B vs Cosentyx at $3.1B.
| Metric | Revlimid | Cosentyx |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $12,786 | $3,616* |
| Total Medicare Spending Total Medicare Part D spending on this drug | $7.8B | $3.1B |
| Total Claims | 612,000 | 864,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | -3.4%* | 8.9% |
| Generic Available | No | Yes |
| Condition | Cancer | Autoimmune Diseases |
| Total Beneficiaries | 58,000 | 120,000 |
Cosentyx costs 72% less per claim than Revlimid ($3616.00 vs $12786.00). Cosentyx has a generic alternative available. Total Medicare spending: Revlimid at $7.8B vs Cosentyx at $3.1B.